Literature DB >> 16460035

The kinase homology domain of receptor guanylyl cyclase C: ATP binding and identification of an adenine nucleotide sensitive site.

Mahaboobi Jaleel1, Sayanti Saha, Avinash R Shenoy, Sandhya S Visweswariah.   

Abstract

The role of the kinase homology domain (KHD) in receptor guanylyl cyclases is to regulate the activity of the catalytic guanylyl cyclase domain. The KHD lacks many of the amino acids required for phosphotransfer activity and, therefore, is not expected to possess kinase activity. Guanylyl cyclase activity of the receptor guanylyl cyclase C (GC-C) is modulated by ATP, and computational modeling showed that the KHD can adopt a structure similar to protein kinases, suggesting that the KHD is the site for ATP interaction. A monoclonal antibody, GCC:4D7, raised to the KHD of GC-C, fails to react with GC-C in the presence of ATP and ATP analogues that regulate GC-C catalytic activity, indicating that a conformational change occurs in the KHD on ATP binding. Mapping of the epitope of the antibody through the use of recombinant protein constructs and phage display showed that the epitope for GC-C:4D7 lies immediately C-terminal to a critical lysine residue (Lys516 in GC-C), required for ATP interaction in protein kinases. By employing a novel approach utilizing ATP-agarose affinity chromatography, we demonstrate that the intracellular domain of GC-C and the KHD bind ATP. Mutation of Lys516 to Ala abolishes ATP binding. Thus, this report is the first to show direct ATP binding to the pseudokinase domain of receptor guanylyl cyclase C, as well as to identify dramatic conformational changes that occur in this domain on ATP binding, akin to those seen in catalytically active protein kinases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460035     DOI: 10.1021/bi052089x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  The evolution of guanylyl cyclases as multidomain proteins: conserved features of kinase-cyclase domain fusions.

Authors:  Kabir Hassan Biswas; Avinash R Shenoy; Anindya Dutta; Sandhya S Visweswariah
Journal:  J Mol Evol       Date:  2009-06-03       Impact factor: 2.395

2.  The linker region in receptor guanylyl cyclases is a key regulatory module: mutational analysis of guanylyl cyclase C.

Authors:  Sayanti Saha; Kabir Hassan Biswas; Chandana Kondapalli; Nishitha Isloor; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

3.  Receptor guanylyl cyclase C (GC-C): regulation and signal transduction.

Authors:  Nirmalya Basu; Najla Arshad; Sandhya S Visweswariah
Journal:  Mol Cell Biochem       Date:  2009-12-04       Impact factor: 3.396

4.  Cross talk between receptor guanylyl cyclase C and c-src tyrosine kinase regulates colon cancer cell cytostasis.

Authors:  Nirmalya Basu; Rashna Bhandari; Vivek T Natarajan; Sandhya S Visweswariah
Journal:  Mol Cell Biol       Date:  2009-07-20       Impact factor: 4.272

5.  Site-specific N-linked glycosylation of receptor guanylyl cyclase C regulates ligand binding, ligand-mediated activation and interaction with vesicular integral membrane protein 36, VIP36.

Authors:  Najla Arshad; Suhas Ballal; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2012-12-26       Impact factor: 5.157

Review 6.  Pseudokinases-remnants of evolution or key allosteric regulators?

Authors:  Elton Zeqiraj; Daan M F van Aalten
Journal:  Curr Opin Struct Biol       Date:  2010-11-10       Impact factor: 6.809

7.  The pseudokinase domains of guanylyl cyclase-A and -B allosterically increase the affinity of their catalytic domains for substrate.

Authors:  Aaron B Edmund; Timothy F Walseth; Nicholas M Levinson; Lincoln R Potter
Journal:  Sci Signal       Date:  2019-01-29       Impact factor: 9.517

8.  A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties.

Authors:  James M Murphy; Qingwei Zhang; Samuel N Young; Michael L Reese; Fiona P Bailey; Patrick A Eyers; Daniela Ungureanu; Henrik Hammaren; Olli Silvennoinen; Leila N Varghese; Kelan Chen; Anne Tripaydonis; Natalia Jura; Koichi Fukuda; Jun Qin; Zachary Nimchuk; Mary Beth Mudgett; Sabine Elowe; Christine L Gee; Ling Liu; Roger J Daly; Gerard Manning; Jeffrey J Babon; Isabelle S Lucet
Journal:  Biochem J       Date:  2014-01-15       Impact factor: 3.857

9.  Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.

Authors:  John C Flickinger; Jeffrey A Rappaport; Joshua R Barton; Trevor R Baybutt; Amanda M Pattison; Adam E Snook; Scott A Waldman
Journal:  Biomark Med       Date:  2021-01-20       Impact factor: 2.851

10.  Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site.

Authors:  Eric D Scheeff; Jeyanthy Eswaran; Gabor Bunkoczi; Stefan Knapp; Gerard Manning
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.